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A New Hypothesis for Dystonia
In this issue of the Annals, Goto and colleagues present
a new hypothesis concerning the pathophysiology of
dystonia.1 A measure of our limited understanding of
dystonias is the fact that although dystonia is a brain
disorder, the most effective treatment is botulinum
toxin chemodenervation at the neuromuscular junc-
tion. Ignorance of the mechanisms of dystonia is an
obstacle to developing mechanism-based therapies and
to evaluating putative animal models. Accumulated
data indicate that dystonias result from basal ganglia
dysfunction, a conclusion supported by lesion data,
neuroimaging results, and most recently by electro-
physiological data from dystonic patients. An intrigu-
ing idea is that primary basal ganglia dysfunction
causes abnormalities of sensorimotor integration at the
level of the neocortex.2
Goto and colleagues use a sophisticated version of
traditional clinicopathological correlation to investigate
striatal changes in X-linked dystonia parkinsonism
(XPD; DYT3; Lubag), a disorder endemic on the is-
land of Panay in the Philippines. In XPD, men de-
velop marked, usually generalized, dystonia followed by
parkinsonism in the later years of life. This experiment
of nature allows comparison of striatal changes in the
dystonic and parkinsonian phases of the disease. Stria-
tal neurons consist of two broad categories, interneu-
rons whose axonal arborizations are restricted to the
striatum itself, and GABAergic projection neurons
whose primary axons project to the pallidum or the
substantia nigra. Projection neurons comprise the great
majority of striatal neurons and can be subdivided fur-
ther on the basis of their projection targets, neuropep-
tide expression, and expression of other markers, nota-
bly some calcium binding proteins. A basic distinction
is between striosomal projection neurons and matrix
projection neurons. Striosomal projection neurons
project mainly to dopaminergic substantia nigra pars
compacta neurons, whereas the matrix contains rela-
tively segregated populations of neurons projecting to
the different components of the globus pallidus or the
substantia nigra pars reticulata. Differential loss or dys-
function of matrix projection neurons is correlated
with other movement disorders.3–5 Preferential, early
loss of matrix neurons projecting to the lateral segment
of the globus pallidus is correlated with expression of
choreoathetosis in Huntington’s disease. In Parkinson’s
disease, loss of striatal dopaminergic innervation alters
the balance of matrix projection neuron subpopulation
activities in a way that results in altered basal ganglia
output to the thalamus.
Using immunohistochemistry to identify various
populations of striatal projection neurons, Goto and
colleagues show convincingly that dystonic XPD
(XPD-D) is marked by differential loss of striatal pro-
jection neuron subpopulations. They show very nicely
that striosomal projection neurons are lost. Their data
indicate partial loss of matrix projection neurons as
well in XPD-D with what seems to be approximately
equivalent loss of matrix neurons projecting to either
segment of the globus pallidus or the substantia nigra
pars reticulata. In the more advanced XPD-P cases, vir-
tually all striatal projection neurons appear to be lost.
This leads to the suggestion that dystonia results from
preferential loss of striosomal projection neurons, per-
haps altering the behavior of dopaminergic nigrostriatal
neurons in a way that causes dystonia. This hypothesis
has several attractions. It represents a further and novel
articulation of popular models of basal ganglia dysfunc-
tion based on degeneration or dysfunction of matrix
projection neurons. These models had difficulty ex-
plaining dystonia.6 In addition, Goto and colleagues’
suggestion that alteration of dopaminergic neuron ac-
tivity is involved in the pathophysiology of dystonia
also makes sense. Some known causes of dystonia, such
as dopa-responsive dystonia (DRD; DYT5; Segawa’s
syndrome) or dystonic phenomena in fluctuating Par-
kinson’s patients, definitely involve dopaminergic dys-
function.
These data admit another interpretation. Connec-
tional and some physiological data suggest the existence
of fine-grained matrix compartments in an organiza-
tion that is based more on patterns of corticostriate in-
nervation than output connections, so-called matri-
somes.7–10 It is possible that Goto and colleagues have
identified both relatively preferential loss of striosomal
projection neurons and some subpopulations of matri-
somal neurons. Dystonia could result from early, pref-
erential loss of specific matrisome subpopulations or
from combined loss of striosomal projection neurons
and some matrisome subpopulations. The question of
which interpretation of these data is correct is much
less important than the fact that these hypotheses sug-
gest fruitful and doable experiments. Striatal specimens
from subjects with early mild XPD or other forms of
generalized dystonia should be examined for evidence
of striosomal and matrisomal projection neuron loss.
Further work along these lines could markedly advance
our understanding of dystonia. The results of Goto
and colleagues underscore the continuing importance
that understanding the basic anatomy and physiology
of the basal ganglia has for exploring movement disor-
ders.
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